HomeInsightsStock Comparison

Nectar Lifescience Ltd vs Norris Medicines Ltd Stock Comparison

Nectar Lifescience Ltd vs Norris Medicines Ltd Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

  • The Latest Trading Price of Nectar Lifescience Ltd is ₹ 12.43 as of 06 May 10:19 . The P/E Ratio of Nectar Lifescience Ltd changed from 21.5 on March 2022 to 0 on March 2025 . This represents a CAGR of -100.00% over 4 yearsThe P/E Ratio of Norris Medicines Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Nectar Lifescience Ltd changed from ₹ 417.13 crore on March 2021 to ₹ 515.35 crore on March 2025 . This represents a CAGR of 4.32% over 5 yearsThe Market Cap of Norris Medicines Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Nectar Lifescience Ltd for the Dec '25 is ₹ 88.81 crore as compare to the Sep '25 revenue of ₹ 0.74 crore. This represent the growth of 11901% The revenue of Norris Medicines Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Nectar Lifescience Ltd for the Dec '25 is ₹ 33.53 crore as compare to the Sep '25 ebitda of ₹ -175 crore. This represent the decline of -119% The ebitda of Norris Medicines Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Nectar Lifescience Ltd changed from ₹ 2.97 crore to ₹ 14.27 crore over 7 quarters. This represents a CAGR of 145.20% The net profit of Norris Medicines Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Nectar Lifescience Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Norris Medicines Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Nectar Lifescience Ltd

  • Nectar Lifescience Limited was initially incorporated on June 27, 1995 as 'Surya Medicare Limited'.
  • On March 26, 2004, Company changed the name from 'Surya Medicare Limited' to 'Nectar Lifescience Limited'.
  • NECLIFE is an integrated pharmaceutical organization, engaged in manufacturing and delivering high quality pharmaceutical products.
  • It is a global pharmaceutical company specializing in Cephalosporins.
  • Nectar excels in Cephalosporin APIs production with certified facilities meeting global standards.

About Norris Medicines Ltd

  • Norris Medicines Limited was established in September, 1990 as a small scale unit at GIDC Estate, Ankleshwar to manufacture non sterile dosage e.g. tablets, capsules, Liquid Orals, Copical ointments.
  • The Company was subsequently converted into Public Limited Company on March 7, 1992.
  • The unit expanded to manufacture Sterile dosage in form of Ampoules & Vials. The Company got into the business in the year 1990.
  • Commercial production of the formulation unit commenced in Nov.'91.
  • The production unit expanded to manufacture Sterile dosage in form of Ampoules & Vials.

FAQs for the comparison of Nectar Lifescience Ltd and Norris Medicines Ltd

Which company has a larger market capitalization, Nectar Lifescience Ltd or Norris Medicines Ltd?

Market cap of Nectar Lifescience Ltd is 238 Cr while Market cap of Norris Medicines Ltd is 14 Cr

What are the key factors driving the stock performance of Nectar Lifescience Ltd and Norris Medicines Ltd?

The stock performance of Nectar Lifescience Ltd and Norris Medicines Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Nectar Lifescience Ltd and Norris Medicines Ltd?

As of May 6, 2026, the Nectar Lifescience Ltd stock price is INR ₹12.28. On the other hand, Norris Medicines Ltd stock price is INR ₹14.75.

How do dividend payouts of Nectar Lifescience Ltd and Norris Medicines Ltd compare?

To compare the dividend payouts of Nectar Lifescience Ltd and Norris Medicines Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions